Japan Health Minister Eyes GSK's H1N1 Flu Vaccine Safety Issues
This article was originally published in PharmAsia News
Executive Summary
Japanese health authorities are taking a cautious look at GlaxoSmithKline's H1N1 flu vaccine after the company requested that Canada stop using one batch of its product